MAY 30 - 31 2013
Clinical Diagnostics 2013
240 39 6409

This year will be our 5th annual Clinical Diagnostics online conference. Attendees can earn free CME and CE Credits. The theme of this conference is a range of medical and clinical and research topics such as Personalized Healthcare, Pathology, Oncology, Infectious Disease, Laboratory Testing, Cardiology, Diabetes, Point of Care, Molecular Diagnostics, Hematology, Automation, Nutrition, Vitamin D, Allergy, Clinical Research, Mass Spectrometry, and much more.

This event will bring together clinicians, researchers, medical experts and professionals from around the world to learn about recent advances in clinical diagnostics, research and medicine. This conference offers an amazing opportunity as it is free to participants, and there will be no out-of-pocket expenses for travel. However, participants will still benefit from interacting with a global community of like-minded colleagues, without leaving the comfort of their office or home.

Conference participants will be able to:


• Attend interactive live streaming video sessions
• Have their questions answered in real-time by industry experts
• Receive Free CME and CE Continuing Education Credits
• Chat live with peers and speakers
• Browse a virtual exhibit floor for solution providers

No crowded airports, delayed flights or expensive hotel rooms, but still the look and feel of a first-rate conference with world renowned experts. Participants also benefit from the fact that experts and vendors are more accessible, no more waiting in line to speak to someone. Think it is too good to be true? Checkout the venue and become a believer.


Speakers:

Show Resources
Agenda
All times are Pacific Time
  • MAY 30, 2013 08:00 AM PDT
    Speaker: John Backus, PhD
  • MAY 30, 2013 09:00 AM PDT
    Speaker: Michael J Mann, MD
    SEE ABSTRACT | Continuing Education: CE
  • MAY 30, 2013 11:00 AM PDT
    Speaker: Steve Friedland
  • MAY 30, 2013 12:00 PM PDT
    Speaker: Janice Au-Young, PhD
  • MAY 31, 2013 09:00 AM PDT
    Speaker: Jerry Boonyaratanakornkit, MS
  • MAY 30, 2013 08:00 AM PDT
    Speaker: John Backus, PhD
  • MAY 30, 2013 09:00 AM PDT
    Speaker: Michael J Mann, MD
    SEE ABSTRACT | Continuing Education: CE
  • MAY 30, 2013 11:00 AM PDT
    Speaker: Steve Friedland
  • MAY 30, 2013 12:00 PM PDT
    Speaker: Janice Au-Young, PhD
  • MAY 31, 2013 09:00 AM PDT
    Speaker: Jerry Boonyaratanakornkit, MS
Speakers

  • John Backus, PhD
    Director, Scientific Affairs, Ortho Clinical Diagnostics
    Biography
      John Backus, Ph.D. is Director, Scientific Affairs, Ortho Clinical Diagnostics, Part of the Johnson & Johnson Family of Companies. John has 20 years of experience in the In Vitro Diagnostics (IVD) industry. He has held a variety of scientific / managerial positions at Eastman Kodak, Gen-Probe, Sigma, Veridex, and Ortho Clinical Diagnostics, primarily focused on IVD Assay / Technology Development and Clinical Verification and Validation of diagnostic biomarkers to address significant unmet needs in Metabolic Disease, Cardiovascular Disease, Acute Care, Oncology, Reproductive Health, and Infectious Disease. John led the development of the first FDA-approved intra-operative molecular cancer diagnostic and has 13 issued U.S. patents, primarily related to nucleic acid purification, amplification, and detection technologies. John received his Ph.D. in Biochemistry from the University of Rochester. His thesis research focused on elucidation of the RNA sequence elements required for mammalian apoB mRNA editing by the editosome macromolecular complex.
    • Michael J Mann, MD
      Associate Professor of Surgery, Division of Adult Cardiothoracic Surgery, Chief of General Thoracic Surgery, University of California, San Francisco, VA Medical Center
      Biography
        Michael J. Mann, M.D. is a leader in the development of genetic and molecular therapies and diagnostics for thoracic and cardiovascular disease. Dr. Mann joined the UCSF Thoracic Oncology Program in 2003 as a cardiothoracic surgeon. He had received an A.B. in synthetic chemistry from Princeton University and an M.D. from Stanford University, and was awarded a Ruth L. Kirschstein National Research Service Award (NRSA) Research Training Fellowship through the NIH. Dr. Mann completed his General Surgery residency at Brigham and Women's Hospital/Harvard Medical School, where he also served on the Faculty of Cardiovascular Medicine, and completed his Cardiothoracic Surgery fellowship at UCSF. Dr. Mann is widely admired for his teaching skills and is Associate Director of the Thoracic Surgery Training Program at UCSF. He holds memberships in numerous professional organizations, including the Society of Thoracic Surgeons, American College of Surgeons, American Heart Association, and the Massachusetts Medical Society. Highly respected by his peers, Dr. Mann was named to the list of U.S. News "Top Doctors;" his areas of clinical expertise include lung cancer, management of metastatic disease in the chest, sarcoma, mesothelioma, and minimally invasive (video-assisted) thoracoscopic surgery. He has received numerous awards including the Cardiovascular Medicine Award for Excellence in Research and the William Randolph Hearst Endowment for Young Investigators. Dr. Mann also serves as a scientific reviewer for numerous professional journals.   While on the faculty at Harvard Medical School, Dr. Mann founded the Cardiovascular Gene Therapy Group. He also invented several novel drug and delivery technologies and helped pioneer the application of gene regulation and vascular biology principles to the problem of coronary bypass graft failure. This led to one of the first large scale programs to evaluate the surgical integration of an advanced molecular therapy. More recently, Dr. Mann's focus on oncogenic signaling pathways and molecular profiles of lung cancer and sarcoma has led to the development and international validation of a molecular diagnostic assay that has enabled personalization of the management of early stage lung cancer. Dr. Mann's research in genetic and molecular therapies has been widely recognized, and he is a founder of the first international co-operative study group designed to harness immense untapped clinical research resources in mainland China. He is currently an Associate Investigator in the UCSF Cardiovascular Research Institute, has served as a scientific advisor to the American Heart Association, to the NIH Recombinant-DNA Advisory Committee and to numerous device and pharmaceutical companies, and his Cardiothoracic Translational Research Laboratory has enjoyed continuous NIH R01 funding since its founding in 2006.
      • Steve Friedland
        Director, ValuMetrix Services, Ortho Clinical Diagnostics
        Biography
          With 30 years experience in the healthcare field, Steve has a proven track record of developing new business designs, leading high performance teams and exceeding client expectations. For the past 22 years at Ortho-Clinical Diagnostics, Inc., he has held numerous management positions, helping to build organizational capability in support of the top North American Integrated Healthcare Systems. ValuMetrix® Services was established in 1999 to support those strategic partners.   Today, ValuMetrix Services uses a proprietary Process Excellence model to improve quality, lower costs and transfer the knowledge of Lean, Six Sigma and Design Excellence throughout all hospital operations. ValuMetrix® Services clients achieve breakthrough results in operational efficiency while training staff in the tools of continuous improvement. In addition to tools and skills training, the ValuMetrix® model also builds organizational structure for change management, accountability and real time performance measurement.   Steve's philosophy is that we have an obligation to provide the highest quality affordable healthcare possible. By combining governance systems, change management, high performance team development and the proven tools of Lean and Six Sigma, ValuMetrix® Services offers a unique opportunity to elevate our healthcare clients and the industry to a new standard of quality and effectiveness. Steve understands that those healthcare organizations that build and sustain a culture of continuous improvement with a goal of zero defects will emerge as the industry leaders of the future.  
        • Janice Au-Young, PhD
          Senior Staff Scientist, Medical Sciences R&D, Life Technologies
          Biography
            Janice Au-Young is a Senior Staff Scientist for Companion Diagnostics in the Medical Sciences R&D group at Life Technologies. She has a Ph.D. degree in Microbiology from the University of California, Davis and has performed post-doctoral research at NIH, MIT and UCSF. She has held senior positions working on target and biomarker identification in other leading genomic companies. Janice has been at Life Technologies since 2006 working on platforms in gene expression, genotyping and mutation detection. Currently, her focus is on molecular diagnostics and defining Companion Diagnostics applications whether it is TaqMan qPCR, Capillary Electrophoresis sequencing, or Ion Torrent Next Gen Sequencing.  
          • Jerry Boonyaratanakornkit, MS
            Staff Scientist, Life Technologies
            Biography
              Jerry Boonyaratanakornkit has been part of Life Technologies since 2006 in the Research and Development department of Life Technologies with emphasis on clinical standards and controls. He has developed, Infectious, Respiratory, HAI, Transplantation, and Oncology standards and controls for molecular assays. He has an intense focus on exceeding customer needs and developing products that provide innovative solutions to the clinical lab. In 2010, Jerry led the launch of the EZValidation cloud-based tool that assisted molecular labs in implementing quantitative molecular assays. Subequently in 2013, the next generation tool, EZQC was launched that supported implementing, calibrating, and monitoring of complex quantitative molecular assays.  
            Sponsored By

            For information on becoming a sponsor or exhibitor, please click here.


            Continuing Education (CME/CE/CEU) Credits

            The speakers below have been approved for CME, CE, or CEU credits. To redeem your credits, locate the presentation you watched and click on the CME/CE/CEU buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here


            Help

            General LabRoots Questions

            For bugs, spam, technical support or questions please call +1-714-463-4673 or email support@labroots.com  
            Contact us

            Virtual Events and Webinars

            Supported Configurations

            • Operating System Internet Explorer Firefox Chrome Safari
              Vista IE8+ FF10+ Chrome15+
              Windows 7 IE8+ FF10+ Chrome15+
              Windows 8 IE10 FF10+ Chrome15+
              Mac OS X   FF10+ Chrome15+ Safari5.1+
            • Cookie settings: session cookies enabled
            • Browser configuration must have JavaScript enabled
            • Adobe Flash player 10.2 or later

            To watch our webinars and virtual events a modern browser such as Chrome, Firefox, Safari, or an updated version of Internet Explorer is required.

            Internet Connection

            • A minimum of 100Kbps is recommended for audio-only events
            • A minimum of 300Kbps is recommended for speaker on-video events

            Computer Equipment

            • Screen Resolution: Minimum 1024x768
            • Video Card: 65,000 colors minimum
            • Sound card and speakers (or headphones) for hearing webcast in full format
            • Audio Card: 16-bit minimum
            • RAM: 512MB of free RAM

            Firewall Protocol

            • HTTP on port 80 or HTTPS on port 443
            • Adobe RTMP on port 1935, 80, or 443 with automatic fall-back to RTMPT (RTMP tunneling) on ports 1935, 80 or 443
            • RTMPE (RTMP encrypted) on ports 1935, 80 or 443

            Work-At-Home Attendees

            • If a corporate VPN is used, confirm that your network traffic is not directed over the company VPN. If it is, please turn off the VPN while attending the virtual event.

            For A Seamless Experience

            When using a mobile device, FREE Mobile Apps are available:

            - For viewing Webinars:

            - For viewing Virtual Events

            Attendee Guide

            • To learn more about how the virtual event works for attendees, download the Attendee Guide (PDF).

            Virtual Event and Webinar Support:

            Continuing Education (CME/CE) Support

            Loading Comments...